/news/b/articles/archive/2017/10/03/skolkovo-startup-harnesses-nuclear-medicine-to-diagnose-rare-cancers.aspxPharm-Sintez.Lab , a resident startup of the Skolkovo Foundation’s nuclear cluster, has developed a system for detecting rare forms of cancer in Russian patients. Lev Voloznev, CEO of Pharm-Sintez.Lab, pictured in his lab at the Skolkovo Technopark7.x Production